Overview

Update
IPO / Stock
Went Public on Jan 27, 2015 / NASDAQ:ZSAN
Total Equity Funding
$132.12M in 4 Rounds from 4 Investors
Headquarters:
Fremont, CA
Description:
Zosano Pharma, a biopharmaceutical company, develops products based on the transdermal delivery technology.
Founders:
Categories:
Biopharma, Biotechnology, Medical
Website:
http://zosanopharma.com
Social:

Company Details

Update

Zosano Pharma is a private pharmaceutical company founded in October 2006 and is focused on creating better products with their innovative drug delivery technology.

Their lead program, parathyroid hormone (PTH) transdermal microprojection delivery system has finalized a Phase 2 clinical trial for treating severe osteoporosis. Zosano's objective is to discover and develop therapeutic drug candidates which address large unmet medical needs or have a significant potential for commercialization.

Funding Rounds (10) - $166.22M

Update
DateAmount / RoundValuationLead InvestorInvestors
Aug, 2016$7.54M / Post Ipo Equity0
Feb, 2015$15M / Post Ipo Equity0
Dec, 2014$1.33M / Debt Financing0
Mar, 2014$2.5M / Debt Financing0
Sep, 2013$3.03M / Debt Financing3
Sep, 2011$4.71M / Debt Financing0
Aug, 2010$3.11M / Venture0
Mar, 2010$9.01M / Series B0
Aug, 2009$30M / Series B4
Nov, 2007$90M / Series A4

Current Team (5)

Update

Board Members and Advisors (4)

Update

Offices/Locations (1)

Update
  • Office

    34790 Ardentech Court

    Fremont, CA 94555

    USA

Past Team (1)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos